login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PTC THERAPEUTICS INC (PTCT) Stock News
USA
-
Nasdaq
- NASDAQ:PTCT -
US69366J2006
-
Common Stock
86.25
USD
+3.32 (+4%)
Last: 11/26/2025, 8:00:01 PM
86.19
USD
-0.06 (-0.07%)
After Hours:
11/26/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PTCT Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Chartmill
PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents an Affordable Growth Opportunity
15 days ago - By: Chartmill
PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows Strong Growth Momentum and Technical Health
8 days ago - By: PTC Therapeutics, Inc.
PTC Therapeutics to Host R&D Day
10 days ago - By: The Motley Fool
- Mentions:
TVTX
SUPN
INCY
NBIX
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why
10 days ago - By: The Motley Fool
- Mentions:
TVTX
SUPN
INCY
NBIX
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally
23 days ago - By: Zacks Investment Research
Compared to Estimates, PTC Therapeutics (PTCT) Q3 Earnings: A Look at Key Metrics
23 days ago - By: Zacks Investment Research
- Mentions:
BFRI
PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates
23 days ago - By: PTC Therapeutics, Inc.
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
24 days ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
a month ago - By: PTC Therapeutics, Inc.
PTC Therapeutics to Participate at Upcoming Investor Conferences
a month ago - By: Zacks Investment Research
- Mentions:
PRAX
Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy?
a month ago - By: PTC Therapeutics, Inc.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: PTC Therapeutics, Inc.
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results
2 months ago - By: Zacks Investment Research
- Mentions:
NVS
BIIB
SUPN
Can Biogen Stock Rebound as New Drugs Aim to Offset MS Sales Declines?
2 months ago - By: PTC Therapeutics, Inc.
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Yahoo Finance
- Mentions:
NVS
PTC
PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich’s Ataxia
3 months ago - By: Benzinga
PTC Therapeutics Stock Is Stuck In A Multi-Year Slump
3 months ago - By: PTC Therapeutics, Inc.
PTC Therapeutics to Participate at Upcoming Investor Conferences
3 months ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital
3 months ago - By: Stocktwits
- Mentions:
IWMW
EAOR
PTC Therapeutics Stock In The Spotlight After FDA Refuses Approval For Drug To Treat Neurodegenerative Disease, Analysts Are Divided
4 months ago - By: Zacks Investment Research
PTC Therapeutics (PTCT) Reports Q2 Earnings: What Key Metrics Have to Say
4 months ago - By: Zacks Investment Research
- Mentions:
XOMA
PTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: PTC Therapeutics, Inc.
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Please enable JavaScript to continue using this application.